Sartans in the treatment of high-risk hypertension: the abilities of candesartan
Keyword(s):
This paper presents an overview of the literature on the treatment of arterial hypertension drugs that block the renin-angiotensin-aldosterone system (RAAS) – angiotensin receptor blockers ΙΙ (ARB), whose action is based on inhibition of the RAAS at the AII receptor. ARB candesartan (atakand), along with a strong long-term antihypertensive effect has organoprotective (causes regression of LVH has nephroprotection) antidiabetogennym effect, prevents the development of stroke. Clinical experience suggests candesartan, high efficiency and a good range of security among different categories of hypertensive patients with concomitant pathology, chronic heart failure, diabetes, obesity.
2017 ◽
Vol 40
(2)
◽
pp. 99-106
◽
2004 ◽
Vol 141
(9)
◽
pp. 693
◽
2005 ◽
Vol 142
(5)
◽
pp. 391
2016 ◽
Vol 10
(4)
◽
pp. e32-e33